Yingjun Su

Mouse xenograft models vs GEM models for human cancer therapeutics

Ann Richmond, Yingjun Su · Disease Models & Mechanisms · 2008 · 469 citations · Full text

Medicine, Cancer Biology, Oncology +12

The Chemokine Receptors CXCR1 and CXCR2 Couple to Distinct G Protein-Coupled Receptor Kinases To Mediate and Regulate Leukocyte Functions

Sandeep K. Raghuwanshi, Yingjun Su, Vandana Singh et al. · The Journal of Immunology · 2012 · 149 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Targeting aurora kinases limits tumour growth through DNA damage‐mediated senescence and blockade of NF‐κB impairs this drug‐induced senescence

Yan Liu, Oriana E. Hawkins, Yingjun Su et al. · EMBO Molecular Medicine · 2012 · 97 citations · Full text

Medicine, Cancer Biology, Oncology +17

Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.

Evemie Schutyser, Yingjun Su, Yingchun Yu et al. · PubMed · 2007 · 94 citations · Full text

Life Sciences, Immunology, Cell Signaling +16

CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways

Tammy Sobolik, Yingjun Su, Sam Wells et al. · Molecular Biology of the Cell · 2014 · 88 citations · Full text

Life Sciences, Molecular Biology, Oncology +17